MedTrace Logo

Precisight® Intraocular Lens Implantation for Cataract Treatment

NCT02970487 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2019-03-01

No results posted yet for this study

Summary

The purpose of this study is to determine the refractive outcomes and optimize the clinical features of a new intraocular lens intended to treat the senile cataract.

Conditions

  • Cataract Senile

Interventions

DEVICE

Intraocular implant of the Precisight

Precisight ismplanted in place of the natural cloudy lens, inside the capsular bag.

Sponsors & Collaborators

  • Targomed

    collaborator UNKNOWN

  • InfiniteVision Optics

    lead INDUSTRY

Principal Investigators

  • Harvey S Uy, MD · Peregrine Eye and Laser Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2020-01-31
Completion
2020-07-31

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02970487 on ClinicalTrials.gov